Fulgent Genetics (FLGT) Other Operating Expenses (2016 - 2026)
Fulgent Genetics' Other Operating Expenses history spans 12 years, with the latest figure at -$24.5 million for Q1 2026.
- On a quarterly basis, Other Operating Expenses fell 79.09% to -$24.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$5.2 million, a 12.87% increase, with the full-year FY2025 number at $49.9 million, up 12.87% from a year prior.
- Other Operating Expenses hit -$24.5 million in Q1 2026 for Fulgent Genetics, down from $11.5 million in the prior quarter.
- Over the last five years, Other Operating Expenses for FLGT hit a ceiling of $132.7 million in Q4 2023 and a floor of -$24.5 million in Q1 2026.
- Historically, Other Operating Expenses has averaged $9.8 million across 5 years, with a median of $10.6 million in 2024.
- Biggest five-year swings in Other Operating Expenses: skyrocketed 656.78% in 2023 and later tumbled 224.66% in 2025.
- Tracing FLGT's Other Operating Expenses over 5 years: stood at -$23.8 million in 2022, then skyrocketed by 656.78% to $132.7 million in 2023, then tumbled by 91.31% to $11.5 million in 2024, then fell by 0.23% to $11.5 million in 2025, then tumbled by 313.06% to -$24.5 million in 2026.
- Business Quant data shows Other Operating Expenses for FLGT at -$24.5 million in Q1 2026, $11.5 million in Q4 2025, and -$6.5 million in Q3 2025.